The present role of bone marrow and stem cell transplantation in the therapy of children with acute leukemia

Annals of the New York Academy of Sciences

Volumn 824, Issue , 1997, Pages 38-64

  Ladenstein, Ruth ^a   Peters, Christina ^a   Gadner, Helmut ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER REGRESSION; CHILDHOOD LEUKEMIA; CHROMOSOME ANALYSIS; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE CLASSIFICATION; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; META ANALYSIS; STEM CELL TRANSPLANTATION;

EID: 0030664555     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb46208.x     Document Type: Conference Paper

References (124)

1. HOROWITZ, M. M. 1993. Results of bone marrow transplants from human leukocyte antigen-identical sibling donors for treatment of childhood leukemias. A report from the International Bone Marrow Transplant Registry. Am. J. Pediatr. Hematol. Oncol. 15(1): 56-64.
2. MELONI, G. 1992. Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: A pilot study. Leukemia 6(8): 780-785.
3. PINKEL, D. 1993. Bone marrow transplantation in children. J. Pediatr. 122(3): 331-341.
4. HOELZER, D. 1993. Acute lymphoblastic leukemia - progress in children, less in adults [editorial; comment]. N. Engl. J. Med. 329(18): 1343-1344.
5. PUI, C. H. 1995. Treatment of childhood leukemias. Curr. Opin. Oncol. 7(1): 36-44.
6. REITER, A. 1994. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multi-centre trial ALL BFM 86. Blood 84: 3122-3133.
7. RIVERA, G. K. 1993. Treatment of acute lymphoblastic leukemia: 30 years of experience at St. Jude Children's research hospital. N. Engl. J. Med. 329: 1289-1295.
8. CHESSELLS, J. M. 1995. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia. Lancet 345(8943): 143-148.
9. CHESSELLS, J. M. 1992. Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: Experience in MRC UKALL X. Lancet 340(8819): 565-568.
10. EBELL, W. 1992. Chemotherapy versus bone marrow transplantation in childhood acute lymphoblastic leukaemia. BFM Study Group. Eur. J. Pediatr. 151(Suppl 1): S50-S54.
11. RIEHM, H. 1990. Results and significance of 6 randomised trials in four consecutive ALL-BFM studies. Haematol. Blood Trans. 33: 349-450.
12. CORTES, J. E. 1995. Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy. Cancer 76(12): 2393-2417.
13. MILLER, D. R. 1990. Acute lymphoblastic leukemia in children: An update of clinical, biological, and therapeutic aspects. Crit. Rev. Oncol. Hematol. 10(12): 131-164.
14. PUI, C. H. H. 1989. Prognostic importance of structural abnormalities in children with hyperdiploid (>50 chromosomes) acute lymphoblastic leukemia. Blood 73: 1963-1967.
15. PUI, C. H. 1990. Near triploid and near tetra-ploid acute lymphoblastic leukemia of childhood. Blood 76: 590-596.
16. PUI, C. H. 1990. Clinical presentation karyotypic characterisation and treatment outcome of childhood acute lymphoblastic leukemia with a near haploid or hyploid <45 line. Blood 75: 1170-1177.
17. JASMIN, C. 1991. Concepts of remission, curability and lineage involvement in relationship to the problems of minimal residual leukaemia. Baillieres Clin. Haematol. 4(3): 599-607.
18. CONSOLINI, R. 1993. Evaluation of minimal residual disease in high risk childhood acute lymphoblastic leukemia using an immunological approach during complete remission. AIEOP Cooperative Group for Immunology of Acute Leukemias. Haematologica 78(5): 297-305.
19. KROLEWSKY, J. J. 1989. Molecular genetic approaches in the diagnosis and classification of lymphoid malignancies. Hematol. Pathol. 3: 45-61.
20. FELIX, C. A. 1987. T-cell receptor alpha, beta and gamma genes in T-cell and pre-B cell acute lymphoblastic leukemia. J. Clin. Invest. 80: 540-556.
21. ADRIAANSEN, H. J. 1991. Immunoglobulin and T-cell gene receptor gene rearrangements in acute non-lymphocytic leukemias: Analysis of 54 cases and a review of the literature. Leukemia 9: 744-751.
22. SCHUTT, S. 1990. Clinical applications of the study of immunoglobulin and T-cell receptor gene rearrangements in acute leukemia and non-Hodgkin's lymphoma in children. Klin. Padiatr. 202(4): 218-223.
23. SCHRAPPE, M. 1994. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: The significance of initial therapy response in blood and bone marrow]. Klin. Padiatr. 206(4): 208-221.
24. GAJJAR, A. 1995. Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia. Blood 86(4): 1292-1295.
25. EDEN, O. B. 1991. Results of Medical Research Council Childhood Leukemia Trial UKALL VIII. Br. J. Haematol. 78: 187-196.
26. REITER, A. 1992. Favourable outcome of B-cell acute lymphoblastic leukemia in childhood: A report of three consecutive studies of the BFM group. Blood 80: 2471-2478.
27. BIGGS, J. C. 1992. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood 80(4): 1090-1093.
28. 27a. TESTI, A. M. 1992. Treatment of primary refractory or relapsed acute lymphoblastic leukemia (ALL) in children. Am. Oncol. 3(9): 765-767.
29. FLETCHER, J. A. 1991. Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood 77(3): 435-439.
30. HENZE, G. 1991. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood 78(5): 1166-1172.
31. BARRETT, A. J. 1994. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission [see comments]. N. Engl. J. Med. 331(19): 1253-1258.
32. MINIERO, R. 1995. Relapse after first cessation of therapy in childhood acute lymphoblastic leukemia: A 10-year follow-up study. Italian Association of Pediatric Hematology-Oncology (AIEOP). Med. Pediatr. Oncol. 24(2): 71-76.
33. SADOWITZ, P. D. 1993. Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group Study. Blood 81: 602-609.
34. HENZE, G. 1994. Chemotherapy for relapsed childhood acute lymphoblastic leukemia: Results of the BFM study group. Haematol. Blood Transf. 36: 374-379.
35. JOHNSON, F. L. 1990. Role of bone marrow transplantation in childhood lymphoblastic leukemia. Hematol. Oncol. Clin. N. Am. 4(5): 997-1008.
36. SANDERS, J. E. 1987. Marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 70: 324-326.
37. KERSEY, J. H. 1987. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N. Engl. J. Med. 317: 461-467.
38. DOPFER, R. 1991. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: Results of the German Cooperative Study. Blood 78(10): 2780-2784.
39. GORIN, N. C. 1993. Stem cell transplantation in acute leukemia. Ann. N. Y. Acad. Sci. 770: 262-287.
40. MOUSSALEM, M. 1995. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: Factors predictive of survival, relapse and graft-versus-host disease. Bone Marrow Transplant. 15(6): 943-947.
41. PINKEL, D. 1992. Therapy of acute lymphoid leukemia in children. Leukemia 6(Suppl 2): 127-131.
42. BUTTURINI, A. 1987. Which treatment for childhood acute lymphoblastic leukemia in second remission? Lancet i: 429-432.
43. RIVERA, G. K. 1986. Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. N. Engl. J. Med. 315: 273-278.
44. DINSMORE, R. 1983. Allogeneic bone marrow transplantation for patients with acute lymphoblastic leukemia. Blood 62: 381-388.
45. BÜHRER, C. 1993. Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. Med. Pediatr. Oncol. 21(7): 470-476.
46. BORGMANN, A. 1995. Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: A matched-pair analysis. The Berlin-Frankfurt-Munster Study Group. Lancet 346(8979): 873-876.
47. KERSEY, J. H. 1987. Comparison of autologous and allogeneic bone marrow transplantation for treatment with high-risk refractory acute lymphoblastic leukemia. N. Engl. J. Med. 317: 461-467.
48. SALLAN, S. E. 1989. Autologous bone marrow transplantation for acute lymphoblastic leukemia. J. Clin. Oncol. 7: 1594-1601.
49. CAHN, J. Y. 1991. The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: A cooperative study of 62 patients. Bone Marrow Transplant. 7: 1-4.
50. BILLETT, A. L. 1993. Autologous bone marrow transplantation in childhood acute lymphoid leukemia with use of purging. Am. J. Pediatr. Hematol. Oncol. 15(2): 162-168.
51. DOUAY, L. 1995. Amifostine improves the antileukemic therapeutic index of mafosfamide: Implications for bone marrow purging. Blood 86(7): 2849-2855.
52. SCHROEDER, H. 1991. High dose melphalan and total body irradiation with autologous marrow rescue in childhood acute lymphoblastic leukaemia after relapse. Bone Marrow Transpl. 7(1): 11-15.
53. BILLETT, A. L. 1993. Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia. Blood 81(6): 1651-1657.
54. UDERZO, C. 1995. High-dose vincristine, fractionated total-body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission: A 7-year Italian multicentre study. Br. J. Haematol. 89(4): 790-797.
55. ROSSETTI, F. 1993. ABMT for early isolated extramedullary relapse of childhood ALL. Bone Marrow Transpl. 12(5): 549.
56. LONNERHOLM, G. 1992. Autologous bone marrow transplantation in children with acute lymphoblastic leukemia. Acta Paediatr. 81(12): 1017-1022.
57. COLLESELLI, P. 1994. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in remission: First choice for isolated extramedullary relapse? Bone Marrow Transpl. 14(5): 821-825.
58. SCHMID, H. 1993. Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia. Bone Marrow Transpl. 12(6): 597-602.
59. GILMORE, M. J. 1991. Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission. Bone Marrow Transpl. 8(1): 19-26.
60. BORGMANN, A. 1995. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: A comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group. Bone Marrow Transpl. 15(4): 515-521.
61. PARSONS, S. K. 1996. Relapsed acute lymphoblastic leukemia: Similar outcomes for autologous and allogeneic marrow transplantation in selected children. Bone Marrow Transpl. 17: 763-768.
62. GARIN, L. 1996. Strong increase in the percentage of the CD8bright+ CD28- T-cells and delayed engraftment associated with cyclosporine-induced autologous GVHD. Eur. J. Haematol. 56(3): 119-123.
63. BAUMGARTEN, E. 1994. Low-dose natural interleukin-2 and recombinant interferon-gamma following autologous bone marrow grafts in pediatric patients with high-risk acute leukemia. Leukemia 8(5): 850-855.
64. SOIFFER, R. J. 1993. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse. Bone Marrow Transplant. 12(3): 243-251.
65. ROBINSON, N. 1996. Phase I trial of interleukin-2 after unmodified HLA-matched sibling bone marrow transplantation for children with acute leukemia. Blood 87(4): 1249-1254.
66. UDERZO, C. 1990. Treatment of isolated testicular relapse in childhood acute lymphoblastic leukemia: An Italian multicenter study. Associazione Italiana Ematologia ed Oncol. Pediatr. J. Clin. Oncol. 8(4): 672-677.
67. UDERZO, C. 1995. Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: Ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association. J. Clin. Oncol. 13(2): 352-358.
68. WEISDORF, D. 1987. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: Prolonged survival associated with acute graft versus host disease. J. Clin. Oncol. 5: 1348-1355.
69. RINGDEN, O. 1993. Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia. Blood 81(4): 1094-1100.
70. HURWITZ, C. A. 1995. Treatment of patients with acute myelogenous leukemia: review of clinical trials of the past decade. J. Pediatr. Hematol. Oncol. 17(3): 185-197.
71. VORMOOR, J. 1996. Therapy of childhood acute myelogenous leukemias. Ann. Hematol. 73(1): 11-24.
72. LIE, S. O. 1996. A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome Nordic Society of Paediatric Haematology and Oncology (NOPHO). Br. J. Haematol. 94(1): 82-88.
73. RITTER, J. 1992. Treatment results of three consecutive German childhood AML trials: BFM-78, -83, and -87. AML-BFM-Group. Leukemia 6(Suppl 2): 59-62.
74. STARK, B. 1995. A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8:16)(p11:p13), in a patient with the variant t(8:19)(p11:q13) - case report and review of the literature. Leuk. Res. 19(6): 367-379.
75. LION, T. 1992. The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children. Blood 79(12): 3325-3330.
76. RIBEIRO, R. C. 1993. Acute megakaryoblastic leukemia in children and adolescents: A retrospective analysis of 24 cases. Leuk. Lymph. 10(4-5): 299-306.
77. BARANGER, L. 1990. Monosomy-7 in childhood hemopoietic disorders. Leukemia 4(5): 345-349.
78. KALRA, R. 1995. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood 86(12): 4579-4586.
79. CREUTZIG, U. 1990. Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78, AML-BFM Study Group, Blood 75(10): 1932-1940.
80. CREUTZIG, U. 1992. Comparison of chemotherapy alone with allogeneic bone marrow transplantation in first full remission in children with acute myeloid leukemia in the AML-BFM-83 and AML-BFM-87 studies - matched pair analysis. Klin. Padiatr. 204(4): 246-252.
81. DINNDORF, P. 1995. Bone marrow transplantation for children with acute myelogenous leukemia. J. Pediatr. Hematol. Oncol. 17(3): 211-224.
82. SIERRA, J. 1996. Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation. J. Clin. Oncol. 14(4): 1353-1363.
83. SELVAGGI, K. J. 1994. Improved outcome for high-risk acute myeloid leukemia patients using autologous bone marrow transplantation and monoclonal antibody purged bone marrow. Blood 83(6): 1698-1705.
84. LADENSTEIN, R. 1996. BMT from unrelated or family donors other than HLA identical siblings. GVHD prophylaxis, incidence and treatment. Bone Marrow Transpl. 18(2): 86-91.
85. BALDUZZI, A. 1995. Unrelated donor marrow transplantation in children. Blood 86(8): 3247-3256.
86. CORNISH, J. 1996. Unrelated donor bone marrow transplant in childhood ALL. The role of T-cell depletion. Bone Marrow Transpl. 18(2): 31-35.
87. TAKAHASHI, S. 1994. Recombinant human glycosylated granulocyte stimulating factor (rhG.CSF) combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia. Bone Marrow Transpl. 13: 239-245.
88. BROWN, R. A. 1995. High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: A study by the North American Marrow Transplant Group. Blood 85(5): 1391-1395.
89. CLIFT, R. G. 1992. Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. J. Clin. Oncol. 19(11): 1723-1729.
90. CHAO, N. J. 1993. Busulfan/etoposide - initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia. Blood 81(2): 319-323.
91. CRILLEY, P. 1990. Bone marrow transplantation following busulfan and cyclophosphamide for acute myelogenous leukemia. Bone Marrow Transpl. 5(3): 187-191.
92. SANZ, M. A. 1993. Busulfan plus cyclophosphamide followed by autologous blood stemcell transplantation for patients with acute myeloblastic leukemia in first complete remission: A report from a single institution [see comments] J. Clin. Oncol. 11(9): 1661-1667.
93. MICHEL, G. 1994. Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation - a report from the Societe Francaise de Greffe de Moelle. J. Clin. Oncol. 12(6): 1217-1222.
94. WOODS, W. G. 1996. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood 87(12): 4979-4989.
95. HERMANN, J. 1992. Results of allogenic and autologous bone marrow transplantation in children with acute myeloid leukemia. Kinderarztl-Prax. 60(2): 35-39.
96. SHAW, P. J. 1994. Childhood acute myeloid leukemia: Outcome in a single centre using chemotherapy and consolidation with busulphan/cyclophosphamide for bone marrow transplantation. J. Clin. Oncol. 12(10): 2138-2145.
97. TIEDEMANN, K. 1993. Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission. Blood 82(12): 3730-3738.
98. DINI, G. 1994. Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO). Bone Marrow Transpl. 13(6): 771-776.
99. AMADORI, S. 1993. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group. J. Clin. Oncol. 11(6): 1046-1054.
100. ZITTOUN, R. A. 1995. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell-Adulto (GIMEMA) Leukemia Cooperative Groups. N. Engl. J. Med. 332(4): 217-223.
101. MICHEL, G. 1996. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Bone Marrow Transpl. 17(2): 191-196.
102. RAVINDRANATH, Y. 1996. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group. N. Engl. J. Med. 334(22): 1428-1434.
103. PETERSEN, F. B. 1993. Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission. J. Clin. Oncol. 11(7): 1353-1360.
104. LUDWIG, W. D. 1989. Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia. Leukemia 3(6): 431-439.
105. FELIX, C. A. 1987. Immunoglobulin and T cell receptor gene configuration in acute lymphoblastic leukemia of infancy. Blood 70(2): 536-541.
106. SATHER, H. 1986. Age at diagnosis in childhood acute lymphoblastic leukemia. Med. Pediatr. Oncol. 14: 166-172.
107. CHRIST, W. M. 1986. Clinical and biological features predict a poor prognosis in acute lymphoid leukemias in infants: A pediatric oncology group study. Blood 67: 135-140.
108. PUI, C. H. 1995. Biology and treatment of infant leukemias. Leukemia 9: 762-769.
109. KOLLER, U. 1989. Phenotypic and genotypic heterogeneity in infant acute leukemia. II. Acute nonlymphoblastic leukemia, Leukemia 3(10): 708-714.
110. JOHNSON, F. L. 1992. Allogeneic marrow transplantation in the treatment of infants with cancer. Br. J. Cancer Suppl. 18: S76-S79.
111. CHESSELLS, J. M. 1994. Acute lymphoblastic leukaemia in infancy: Experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia. Leukemia 8(8): 1275-1279.
112. EMMINGER, W. 1992. Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation. Bone Marrow Transpl. 9(5): 313-318.
113. CASPER, J. 1995. Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood 85(9): 2354-2363.
114. GROVAS, A. 1994. Unrelated donor bone marrow transplants in children. Cell Transplant. 3(5): 413-420.
115. PUI, C. H., D. L. WILLIAMS & S. C. RAIMONDI, et al. 1987. Hypoploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Blood 70: 247-253.
116. FLETCHER, J. A., N. TU, R. TANTRAVAHI & S. E. SALLAN. 1992. Extremely poor prognosis of pediatric acute lymphoblastic leukemia with translocation (9;22): updated experience. Leuk. Lymph. 8(1-2): 75-79.
117. PUI, C. H. 1991. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4, 11;q21;q23): a collaborative study of 40 cases. Blood 71: 440-447.
118. RAIMONDI, S. C. 1990. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J. Clin. Oncol. 8: 1380-1388.
119. NOWELL, P. C. 1990. Chromosome translocations and oncogenes in human lymphoid tumors. Am. J. Clin. Pathol. 94: 229-237.
120. RAIMONDI, S. C. 1989. Childhood lymphoblastic leukemia with chromosomal breakpoints at 11q23. Blood 73: 1627-1634.
121. PUI, C. H. 1991. Characterization of childhood acute leukemia with multiple myeloid and lymphoic markers at diagnosis and at relapse. Blood 78: 1327-1337.
122. HUANG, M. E. 1988. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567-572.
123. WARREL, R. P. 1993. Acute promyelocytic leukemia. N. Engl. J. Med. 329: 177-189.
124. ODOM, L. F., B. C. LAMPKIN, R., TANNOUS, J. D. BUCKLEY & G. D. HAMMOND. 1990. Acute monoblastic leukemia: A unique subtype - a review from the Children's Cancer Study Group. Leuk. Res. 14(1): 1-10.